| Product Code: ETC12962853 | Publication Date: Apr 2025 | Updated Date: Feb 2026 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 | |
In 2024, Greece experienced a steady increase in imports of naltrexone and buprenorphine for its market. The trend indicated a growing demand for these pharmaceutical products within the country during that period.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Greece Naltrexone Buprenorphine Market Overview |
3.1 Greece Country Macro Economic Indicators |
3.2 Greece Naltrexone Buprenorphine Market Revenues & Volume, 2022 & 2032F |
3.3 Greece Naltrexone Buprenorphine Market - Industry Life Cycle |
3.4 Greece Naltrexone Buprenorphine Market - Porter's Five Forces |
3.5 Greece Naltrexone Buprenorphine Market Revenues & Volume Share, By Formulation Type, 2022 & 2032F |
3.6 Greece Naltrexone Buprenorphine Market Revenues & Volume Share, By Mechanism of Action, 2022 & 2032F |
3.7 Greece Naltrexone Buprenorphine Market Revenues & Volume Share, By Application, 2022 & 2032F |
3.8 Greece Naltrexone Buprenorphine Market Revenues & Volume Share, By Administration Method, 2022 & 2032F |
3.9 Greece Naltrexone Buprenorphine Market Revenues & Volume Share, By Patient Group, 2022 & 2032F |
4 Greece Naltrexone Buprenorphine Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness about opioid addiction and the importance of medication-assisted treatment (MAT) |
4.2.2 Government initiatives and policies supporting the use of naltrexone and buprenorphine in addiction treatment |
4.2.3 Growing research and development activities leading to improved formulations and delivery methods for naltrexone and buprenorphine |
4.3 Market Restraints |
4.3.1 Stigma associated with medication-assisted treatment for opioid addiction |
4.3.2 Limited access to healthcare services and treatment facilities in certain regions of Greece |
4.3.3 High cost of naltrexone and buprenorphine treatment for some patients |
5 Greece Naltrexone Buprenorphine Market Trends |
6 Greece Naltrexone Buprenorphine Market, By Types |
6.1 Greece Naltrexone Buprenorphine Market, By Formulation Type |
6.1.1 Overview and Analysis |
6.1.2 Greece Naltrexone Buprenorphine Market Revenues & Volume, By Formulation Type, 2022 - 2032F |
6.1.3 Greece Naltrexone Buprenorphine Market Revenues & Volume, By Oral Tablet, 2022 - 2032F |
6.1.4 Greece Naltrexone Buprenorphine Market Revenues & Volume, By Sublingual Film, 2022 - 2032F |
6.1.5 Greece Naltrexone Buprenorphine Market Revenues & Volume, By Injectable Form, 2022 - 2032F |
6.1.6 Greece Naltrexone Buprenorphine Market Revenues & Volume, By Implant, 2022 - 2032F |
6.1.7 Greece Naltrexone Buprenorphine Market Revenues & Volume, By Combination Form, 2022 - 2032F |
6.2 Greece Naltrexone Buprenorphine Market, By Mechanism of Action |
6.2.1 Overview and Analysis |
6.2.2 Greece Naltrexone Buprenorphine Market Revenues & Volume, By Opioid Receptor Modulation, 2022 - 2032F |
6.2.3 Greece Naltrexone Buprenorphine Market Revenues & Volume, By Partial Agonist, 2022 - 2032F |
6.2.4 Greece Naltrexone Buprenorphine Market Revenues & Volume, By Long-Acting Effect, 2022 - 2032F |
6.2.5 Greece Naltrexone Buprenorphine Market Revenues & Volume, By Sustained Release, 2022 - 2032F |
6.2.6 Greece Naltrexone Buprenorphine Market Revenues & Volume, By Dual Mechanism, 2022 - 2032F |
6.3 Greece Naltrexone Buprenorphine Market, By Application |
6.3.1 Overview and Analysis |
6.3.2 Greece Naltrexone Buprenorphine Market Revenues & Volume, By Opioid Dependence, 2022 - 2032F |
6.3.3 Greece Naltrexone Buprenorphine Market Revenues & Volume, By Withdrawal Management, 2022 - 2032F |
6.3.4 Greece Naltrexone Buprenorphine Market Revenues & Volume, By Relapse Prevention, 2022 - 2032F |
6.3.5 Greece Naltrexone Buprenorphine Market Revenues & Volume, By Maintenance Therapy, 2022 - 2032F |
6.3.6 Greece Naltrexone Buprenorphine Market Revenues & Volume, By Detoxification, 2022 - 2032F |
6.4 Greece Naltrexone Buprenorphine Market, By Administration Method |
6.4.1 Overview and Analysis |
6.4.2 Greece Naltrexone Buprenorphine Market Revenues & Volume, By Oral, 2022 - 2032F |
6.4.3 Greece Naltrexone Buprenorphine Market Revenues & Volume, By Sublingual, 2022 - 2032F |
6.4.4 Greece Naltrexone Buprenorphine Market Revenues & Volume, By Injection, 2022 - 2032F |
6.4.5 Greece Naltrexone Buprenorphine Market Revenues & Volume, By Subcutaneous, 2022 - 2032F |
6.4.6 Greece Naltrexone Buprenorphine Market Revenues & Volume, By Oral, 2022 - 2032F |
6.5 Greece Naltrexone Buprenorphine Market, By Patient Group |
6.5.1 Overview and Analysis |
6.5.2 Greece Naltrexone Buprenorphine Market Revenues & Volume, By Adults, 2022 - 2032F |
6.5.3 Greece Naltrexone Buprenorphine Market Revenues & Volume, By Teenagers, 2022 - 2032F |
6.5.4 Greece Naltrexone Buprenorphine Market Revenues & Volume, By Elderly, 2022 - 2032F |
6.5.5 Greece Naltrexone Buprenorphine Market Revenues & Volume, By Critical Patients, 2022 - 2032F |
6.5.6 Greece Naltrexone Buprenorphine Market Revenues & Volume, By All Ages, 2022 - 2032F |
7 Greece Naltrexone Buprenorphine Market Import-Export Trade Statistics |
7.1 Greece Naltrexone Buprenorphine Market Export to Major Countries |
7.2 Greece Naltrexone Buprenorphine Market Imports from Major Countries |
8 Greece Naltrexone Buprenorphine Market Key Performance Indicators |
8.1 Number of healthcare providers trained in prescribing naltrexone and buprenorphine |
8.2 Percentage of opioid addiction patients receiving naltrexone or buprenorphine treatment |
8.3 Rate of treatment adherence and completion among patients undergoing naltrexone and buprenorphine therapy |
9 Greece Naltrexone Buprenorphine Market - Opportunity Assessment |
9.1 Greece Naltrexone Buprenorphine Market Opportunity Assessment, By Formulation Type, 2022 & 2032F |
9.2 Greece Naltrexone Buprenorphine Market Opportunity Assessment, By Mechanism of Action, 2022 & 2032F |
9.3 Greece Naltrexone Buprenorphine Market Opportunity Assessment, By Application, 2022 & 2032F |
9.4 Greece Naltrexone Buprenorphine Market Opportunity Assessment, By Administration Method, 2022 & 2032F |
9.5 Greece Naltrexone Buprenorphine Market Opportunity Assessment, By Patient Group, 2022 & 2032F |
10 Greece Naltrexone Buprenorphine Market - Competitive Landscape |
10.1 Greece Naltrexone Buprenorphine Market Revenue Share, By Companies, 2025 |
10.2 Greece Naltrexone Buprenorphine Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here